# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-035044
Filing Date
2023-10-02
Accepted
2023-10-02 16:30:36
Documents
3
Period of Report
2023-10-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm | DEF 14A | 258778
2 |  | proxy_1.jpg | GRAPHIC | 1884843
3 |  | proxy_2.jpg | GRAPHIC | 1338952
| Complete submission text file | 0001493152-23-035044.txt |  | 4698202

Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40874 | Film No.: 231300121
SIC: 2834 Pharmaceutical Preparations